Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-030592
Filing Date
2021-07-29
Accepted
2021-07-29 10:49:19
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7931
2 EX-24 DOCUMENT attachment1.htm EX-24 2508
  Complete submission text file 0000899243-21-030592.txt   11898
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Issuer) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods

Mailing Address C/O RXSIGHT, INC. 100 COLUMBIA ALISO VIEJO CA 92656
Business Address
Schwartz Daniel Mark (Reporting) CIK: 0001874073 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40690 | Film No.: 211125603